These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9600963)

  • 61. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic.
    Held W; Raulet DH
    Eur J Immunol; 1997 Nov; 27(11):2876-84. PubMed ID: 9394813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Ly-49D receptor activates murine natural killer cells.
    Mason LH; Anderson SK; Yokoyama WM; Smith HR; Winkler-Pickett R; Ortaldo JR
    J Exp Med; 1996 Dec; 184(6):2119-28. PubMed ID: 8976168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonstochastic coexpression of activation receptors on murine natural killer cells.
    Smith HR; Chuang HH; Wang LL; Salcedo M; Heusel JW; Yokoyama WM
    J Exp Med; 2000 Apr; 191(8):1341-54. PubMed ID: 10770801
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
    Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
    Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The KIR and CD94/NKG2 families of molecules in the rhesus monkey.
    LaBonte ML; Hershberger KL; Korber B; Letvin NL
    Immunol Rev; 2001 Oct; 183():25-40. PubMed ID: 11782245
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of CD94/NKG2 in innate and adaptive immunity.
    Gunturi A; Berg RE; Forman J
    Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.
    Besostri B; Beggiato E; Bianchi A; Mariani S; Coscia M; Peola S; Foglietta M; Boccadoro M; Pileri A; Moretta L; Massaia M
    Br J Haematol; 2000 Apr; 109(1):46-53. PubMed ID: 10848781
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic control of human NK cell repertoire.
    Shilling HG; Young N; Guethlein LA; Cheng NW; Gardiner CM; Tyan D; Parham P
    J Immunol; 2002 Jul; 169(1):239-47. PubMed ID: 12077250
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs.
    Storset AK; Slettedal IO; Williams JL; Law A; Dissen E
    Eur J Immunol; 2003 Apr; 33(4):980-90. PubMed ID: 12672064
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
    J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.
    López-Botet M; Pérez-Villar JJ; Carretero M; Rodríguez A; Melero I; Bellón T; Llano M; Navarro F
    Immunol Rev; 1997 Feb; 155():165-74. PubMed ID: 9059892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes.
    Phillips JH; Chang C; Mattson J; Gumperz JE; Parham P; Lanier LL
    Immunity; 1996 Aug; 5(2):163-72. PubMed ID: 8769479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.
    Brennan J; Mager D; Jefferies W; Takei F
    J Exp Med; 1994 Dec; 180(6):2287-95. PubMed ID: 7964501
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets.
    Toomey JA; Salcedo M; Cotterill LA; Millrain MM; Chrzanowska-Lightowlers Z; Lawry J; Fraser K; Gays F; Robinson JH; Shrestha S; Dyson PJ; Brooks CG
    J Immunol; 1999 Sep; 163(6):3176-84. PubMed ID: 10477585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.